Pricing Log in Create free account
Saturday 17 October 2026 Export COO’s income statement to Excel — free account

The Cooper Companies, Inc.

COO Healthcare Medical Instruments & Supplies

The Cooper Companies, Inc.’s revenue for fiscal 2025 (year ended October 2025) was $4.1 billion, up 5.06% from fiscal 2024. In the quarter to July 2026, revenue was flat, EPS grew 357.1%, free cash flow grew 66.0% and total debt rose 2.66%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five; insiders bought in the last twelve months.

57.94 0.54 +0.94%
Market cap
$10.9B
P/E
19.8×
Fwd P/E
28.7×
Dividend yield
—
F-score
5/9
Altman Z
3.48
Beneish M
−2.50
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

The Cooper Companies, Inc. (COO) Price to free cash flow

Alert me on Price to free cash flow

As of 16 October 2026, The Cooper Companies, Inc. (COO) trades at a price to free cash flow of 16.5×. Over the past ten years it has ranged from 15.2× (September 2026) to 159× (May 2024); the current reading is higher than 1% of that period. That is below the Medical Instruments & Supplies industry median of 25.2× and below the Healthcare sector median of 20.2×.

Price to free cash flow, daily

Embed this chart

Annual newest first

Period Price to free cash flow Change
FY2025 32.1× (55.59%)
FY2024 72.3× 0.74%
FY2023 71.7× 139.49%
FY2022 30.0× (24.36%)
FY2021 39.6× (55.66%)
FY2020 89.3× 161.64%
FY2019 34.1× 27.93%
FY2018 26.7× 5.93%
FY2017 25.2× 5.34%
FY2016 23.9× (52.87%)

Quarterly newest first

Period Price to free cash flow Change
Jul 2026 20.6× (4.41%)
Apr 2026 21.5× (33.01%)
Jan 2026 32.1× 0.17%
Oct 2025 32.1× (6.17%)
43 more quarters

Against its own ten years

Low 15.2× High 159×
Ten-year median 37.3×
Current reading's percentile 1

Price to free cash flow against peers

Company Price to free cash flow
SOLV Solventum Corporation compare n/m
ALGN Align Technology, Inc. compare 15.6×
BAX Baxter International Inc. compare 16.1×
COO The Cooper Companies, Inc. 16.5×
AVTR Avantor, Inc. compare 24.4×
ATR AptarGroup, Inc. compare 25.2×
TFX Teleflex Incorporated compare 33.7×
BLCO Bausch + Lomb Corporation compare 52.3×
RGEN Repligen Corporation compare 162×
Medical Instruments & Supplies industry median 25.2×
Healthcare sector median 20.2×
Market median 14.2×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

More on COO